Enzo Biochem
ENZ
$1.09
Share price
0.00%
Change (1 day)
-57.09%
Change (1 year)
Categories
Enzo Biochem (ENZ) - Total liabilities
Total liabilities on the balance sheet as of January 2024 : $28.3 M
According to Enzo Biochem's latest financial reports the company's total liabilities are $28.3 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Enzo Biochem - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-07-31 | $43.41 M | 105.3% |
| 2022-07-31 | $21.14 M | -53.11% |
| 2021-07-31 | $45.1 M | -16.71% |
| 2020-07-31 | $54.15 M | 162.75% |
| 2019-07-31 | $20.61 M | 0.36% |
| 2018-07-31 | $20.53 M | 9.29% |
| 2017-07-31 | $18.79 M | -15.6% |
| 2016-07-31 | $22.26 M | -13.65% |
| 2015-07-31 | $25.78 M | -6.09% |
| 2014-07-31 | $27.46 M | 10.61% |
| 2013-07-31 | $24.82 M | 23.99% |
| 2012-07-31 | $20.02 M | -3.55% |
| 2011-07-31 | $20.75 M | 13.88% |
| 2010-07-31 | $18.22 M | 11.51% |
| 2009-07-31 | $16.34 M | 0.7% |
| 2008-07-31 | $16.23 M | -5.11% |
| 2007-07-31 | $17.1 M | 188.16% |
| 2006-07-31 | $5.93 M | -27.59% |
| 2005-07-31 | $8.19 M | 32.93% |
| 2004-07-31 | $6.16 M | -5.07% |
| 2003-07-31 | $6.49 M | 42.55% |
| 2002-07-31 | $4.55 M | -15.81% |
| 2001-07-31 | $5.41 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $7.60 B | 26,767.36% | 🇺🇸 USA |
 LabCorp LH | $8.83 B | 31,115.46% | 🇺🇸 USA |
 RadNet RDNT | $1.87 B | 6,532.43% | 🇺🇸 USA |
 Psychemedics PMD | $6.67 M | -76.42% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.73 B | 2,513.57% | 🇺🇸 USA |
 Qiagen QGEN | $2.30 B | 8,052.89% | 🇳🇱 Netherlands |